Patents by Inventor Maurizio Civelli

Maurizio Civelli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6951883
    Abstract: 2H-1-Benzopyran derivatives, processes for their preparation and use thereof for the preparation of pharmaceutical compositions for the prevention and treatment of postmenopausal pathologies.
    Type: Grant
    Filed: January 21, 2002
    Date of Patent: October 4, 2005
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Maurizio Delcanale, Gabriele Amari, Elisabetta Armani, Maurizio Civelli, Elisabetta Galbiati
  • Publication number: 20040106595
    Abstract: 2H-1-Benzopyran derivatives, processes for their preparation and use thereof for the preparation of pharmaceutical compositions for the prevention and treatment of postmenopausal pathologies.
    Type: Application
    Filed: December 22, 2003
    Publication date: June 3, 2004
    Inventors: Maurizio Delcanale, Gabriele Amari, Elisabetta Armani, Maurizio Civelli, Elisabetta Galbiati
  • Publication number: 20030207944
    Abstract: Left ventricular dysfunction is treated by a process, comprising: administering to a subject suffering from left ventricular remodeling a therapeutically effective amount of 5,6-dihydroxy-2-methylaminotetralin, or 5,6-diisobutyroyl-oxy-2-methyl-aminotetralin, or a pharmaceutically acceptable salt thereof in combination with an angiotensin-converting enzyme inhibitor.
    Type: Application
    Filed: April 11, 2003
    Publication date: November 6, 2003
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Stefano Bongrani, Roberta Razzetti, Maurizio Civelli, Alberto Umile, Paolo Chiesi
  • Patent number: 6576671
    Abstract: The invention relates to a method of treatment of left ventricular dysfunction, by administering to a subject suffering from left ventricular remodeling a therapeutically effective amount of 5,6-dihydroxy-2-methylaminotetralin or 5,6-diisobutyroyl-oxy-2-methyl-aminotetralin, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: February 19, 2002
    Date of Patent: June 10, 2003
    Assignee: Chiese Farmaceutici S.p.A.
    Inventors: Stefano Bongrani, Roberta Razzetti, Maurizio Civelli, Alberto Umile, Paolo Chiesi
  • Patent number: 6103760
    Abstract: Left ventricular dysfunction is treated by a process, comprising:administering to a subject suffering from left ventricular remodeling a therapeutically effective amount of 5,6-dihydroxy-2-methylaminotetralin, or 5,6-diisobutyroyl-oxy-2-methyl-aminotetralin, or a pharmaceutically acceptable salt thereof in combination with an angiotensin-converting enzyme inhibitor.
    Type: Grant
    Filed: June 9, 1999
    Date of Patent: August 15, 2000
    Assignee: Chiesi Farmaceuticals S.p.A.
    Inventors: Paolo Chiesi, Stefano Bongrani, Roberta Razzetti, Maurizio Civelli, Alberto Umile
  • Patent number: 6013678
    Abstract: A method of treating congestive heart failure is diclosed comprising administering 5,6-dihydroxy- or 5,6-diisobutyroyloxy-2-methylaminotetralin or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: October 14, 1997
    Date of Patent: January 11, 2000
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Paolo Chiesi, Stefano Bongrani, Roberta Razzetti, Maurizio Civelli, Alberto Umile